Corvion is a pre-clinical stage medical device company, established in 2011 and headquartered in the United States. The company's mission is to introduce fully implanted heart assist technology to the global market for mechanical circulatory support. Corvion is currently focused on developing an implantable rotary blood pump that boasts 3X more efficiency than its competitors. This innovation, combined with a robust and flexible transcutaneous charging technology, is poised to significantly enhance patient outcomes and quality of life.
Specializing in the Health Care and Medical Devices industries, Corvion has positioned itself as a prospective game-changer in cardiac care. Despite not having disclosed its most recent investment details, Corvion's ambitious approach to advancing heart assist technology signifies its potential to capture the attention of venture capital firms seeking impactful opportunities in the medical device space.
There is no investment information
No recent news or press coverage available for Corvion.
We care about your data, and we'd love to use cookies make your experience better.
